WHAT IS THIS TRIAL ABOUT?

The purpose of this study is to evaluate the safety and tolerability of an experimental drug called CAD-1883 in adult patients with ET. This experimental drug is not approved by the FDA; it is authorized for use in clinical trials only. The study is being conducted at research centers in the United States. Patients with a history of tremor who meet the entry criteria as assessed by the study doctor may be considered for study participation.

CRITERIA FOR TRIAL ELIGIBILITY

Choosing to participate in a study is an important personal decision. If you are considering participating in this study, you should speak with your doctor and family members or friends prior to deciding to join. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below.

VIEW ALL DETAILS ON CLINICALTRIALS.GOV

WHERE CAN YOU PARTICIPATE?

Please refer to the map below to obtain details of our current recruiting sites for this trial.

INTERESTED IN JOINING CURRENT OR FUTURE TRIALS?

JOIN US ON OUR MISSION